Skip to main content
. 2021 Dec 17;25(2):59. doi: 10.3892/mmr.2021.12575

Figure 2.

Figure 2.

Inhibition of RANKL-induced expression of osteoclastic marker genes by ZOL. (A) CTR, (B) RANK and (C) TRAP. *P<0.05, **P<0.01 vs. RANKL-only group. ZOL, zoledronic acid; RANKL, receptor activator of nuclear-κB ligand; CTR, calcitonin receptor; TRAP, tartrate-resistant acid phosphatase.